Gestational hypoxia is a common stress to the fetal development and increases the risk of neonatal morbidity. The present study tested the hypothesis that fetal hypoxia results in heightened brain vulnerability to hypoxic-ischemic (HI) injury in neonatal rats via down-regulation of glucocorticoid receptor (GR) in the developing brain. Time-dated pregnant rats were exposed to hypoxia (10.5% O 2 ) from days 15 to 21 of gestation. Brain HI injury was determined in day 10 pups. Maternal hypoxia resulted in asymmetric intrauterine growth restriction in the fetus. The brain HI injury was significantly increased in maternal hypoxia-treated pups as compared with the normoxia control in both males and females. Activation of brain GR by dexamethasone injection into the right lateral ventricle produced a concentration-dependent reduction of HI-induced brain injury in control pups. Maternal hypoxia significantly decreased GR mRNA and protein abundance in the fetal brain and neonatal hippocampus and abolished the dexamethasone-mediated neuroprotective effect in pup brains. This decreased GR expression was resulted from increased DNA methylation, decreased binding of transcription factors Egr-1 and Sp1 to GR gene exon 1 7 and 1 11 promoters, and reduced expression of GR exon 1 7 and 1 11 mRNA variants. The results demonstrate that gestational hypoxia causes epigenetic repression of GR gene expression in the developing brain resulting in the heightened brain vulnerability to HI injury in neonatal rats.
Introduction
Hypoxic-ischemic encephalopathy (HIE) is the most common cause of neonatal brain damage due to systemic asphyxia, which may occur prior, during or after birth (Douglas-Escobar and Weiss, 2012) . HIE occurs in about 2% of full-term infants and close to 60% in premature newborns, and causes significant mortality and long-term neurologic sequelae, including learning disabilities, mental retardation, seizure and cerebral palsy (Graham et al., 2008; Kurinczuk et al., 2010) . Although little is known about the pathogenesis of HIE, recent studies have suggested that adverse intrauterine environment may contribute to aberrant brain development (Li et al., 2012a,b; Tomalski and Johnson, 2010) . Hypoxia is a common form of intrauterine stress, and the fetus may experience prolonged hypoxic stress under a variety of conditions, including pregnancy at high altitude, pregnancy with anemia, placental insufficiency, cord compression, preeclampsia, heart, lung and kidney disease, or with hemoglobinopathy. Although it has been shown that fetal hypoxia affects normal brain development and induces neurological deficits in a variety of behavioral tests in offspring (Li et al., 2012a) , the effect of fetal hypoxia-mediated stress on newborn brain HIE remains elusive.
Many factors may be involved in the stress response in the developing brain. Among them, glucocorticoids are essential for the brain development and play a center role in the response to stress. The effects of glucocorticoids are mainly mediated via binding to glucocorticoid receptors (GRs), and GRs are highly expressed in the developing brain with dynamic and complicated ontogeny. It has been demonstrated in humans and rodents that early life environment and events are critical in programming of tissue-specific GR expression patterns, particularly in the hippocampus (Li et al., 2012a; Mueller and Bale, 2008; Oberlander et al., 2008; Turner et al., 2008 Turner et al., , 2010 Weaver et al., 2005 Weaver et al., , 2007 Xiong and Zhang, 2013) . Both neurodegenerative and neuroprotective effects of glucocorticoids have been reported (Abraham et al., 2001) . Glucocorticoids have been shown to affect the vulnerability of fetal and neonatal brains to hypoxia-ischemia challenge; however, the results were inconsistent and dependent on experimental protocol, dosage, timing, animal age, strains and species (Flavin, 1996; Kauffman et al., 1994; Tombaugh et al., 1992; Tuor, 1995 Tuor, , 1997 Whitelaw and Thoresen, 2000) . It appears that the concentration and duration of glucocorticoid treatment are the two key factors determining either detrimental or beneficial effects of glucocorticoids in the brain. Although exposure to long-term and high levels of glucocorticoids enhances neurotoxic effects in brain injury, physiological or slightly supraphysiological levels of glucocorticoids confer the brain protective effect to HIE challenges (Abraham et al., 2001) . Herein, we present evidence of Available online on ScienceDirect (www.sciencedirect.com). 1 These two authors contribute equally to the paper.
